Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
11/2001
11/06/2001US6313118 Hydroxytryptamine receptor antagonists
11/06/2001US6313117 Succinate derivative compounds useful as cysteine protease inhibitors
11/06/2001US6313116 Phosphodiesterase inhibitors
11/06/2001US6313109 Prenyl transferase inhibitors
11/03/2001CA2345760A1 Pharmaceutical uses for fluoroalkoxybenzylamino and alkoxybenzylamino derivatives of nitrogen containing heterocycles
11/01/2001WO2001081622A2 Diagnosis of diseases associated with dna repair
11/01/2001WO2001081590A2 Protein phosphatases
11/01/2001WO2001081585A2 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001WO2001081562A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001WO2001081540A2 Growth factor which acts through erb b-4 rtk
11/01/2001WO2001081415A2 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/01/2001WO2001081348A1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO[3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS
11/01/2001WO2001081346A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta
11/01/2001WO2001081344A1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines
11/01/2001WO2001081323A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
11/01/2001WO2001081312A2 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001WO2001081311A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
11/01/2001WO2001081295A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists
11/01/2001WO2001080890A2 Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
11/01/2001WO2001080796A1 Minimizing adverse experience associated with oxybutynin therapy
11/01/2001WO2001044239A3 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
11/01/2001WO2001041762A3 Valdecoxib compositions
11/01/2001WO2001041761A3 Valdecoxib compositions
11/01/2001WO2001038311A3 Pyrimidine derivatives as selective inhibitors of cox-2
11/01/2001WO2001029066A3 Basic monocyclic compounds having nk2 antagonist action, processes for their preparation, and formulations containing them
11/01/2001WO2001029015A3 Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
11/01/2001WO2001021620A3 Amine derivatives of benzo-4,5-thieno-2,3-d pyrimidines
11/01/2001WO2001017480A3 Methods and compositions for preventing and treating urinary tract disorders
11/01/2001WO2001010847A3 Novel integrin receptor antagonists
11/01/2001WO2000024780A9 Compositions and methods for treating polycystic kidney disease
11/01/2001US20010036950 Potassium channel openers
11/01/2001US20010036944 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
11/01/2001US20010036921 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
11/01/2001US20010036454 Transfection of lung tissue
11/01/2001CA2407493A1 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
11/01/2001CA2407445A1 Use of 5-thio-, sulfinyl- and sulfonylpyrazolo¬3,4-b|-pyridines as cyclin dependent kinase inhibitors
11/01/2001CA2406855A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001CA2406639A1 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001CA2406272A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists
11/01/2001CA2406264A1 Protein phosphatases
11/01/2001CA2405170A1 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001CA2402808A1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines
10/2001
10/31/2001EP1149903A1 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
10/31/2001EP1149104A2 Pyrrolobenzodiazepine carboxyamide vasopressin agonists
10/31/2001EP1149103A1 Thienylbenzoylbenzazepines as vasopressin agonists
10/31/2001EP1149097A2 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
10/31/2001EP1149096A2 Tricyclic pyridine n-oxides vasopressin agonists
10/31/2001EP1149091A1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
10/31/2001EP1149083A1 Morpholinobenzamide salts
10/31/2001EP1149080A2 Crystalline form of benzoquinoline-3-one derivative as inhibitor of 5-alpha reductase
10/31/2001EP1149072A1 Sulfonamide hydroxamates
10/31/2001EP1148902A1 Method of enhancing needleless transdermal powdered drug delivery
10/31/2001EP1148881A1 USE OF PYRIDAZINO 4,5-$i(b)]INDOLE-1-ACETAMIDE DERIVATIVES FOR PREPARING MEDICINES FOR TREATING DISEASES RELATED TO THE DYSFUNCTION OF PERIPHERAL BENZODIAZEPIN RECEPTORS
10/31/2001EP1148791A1 Protein material for slow digestion and its use
10/31/2001EP0869946B1 Phenylimidazolidines and use thereof as an antiandrogenic agent
10/31/2001EP0811001B1 Benzothiazine dioxides as endothelin antagonists
10/31/2001DE10021246A1 New N-substituted benzamide derivatives are tyrosine kinase KDR and FLT inhibitors useful e.g. for treating tumors, psoriasis, rheumatoid arthritis, diabetic retinopathy or liver sclerosis
10/31/2001CN1320121A Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
10/31/2001CN1320118A Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
10/31/2001CN1319426A Oral traditional Chinese medicine for treating calculus stone in urinary system
10/31/2001CN1073988C Substituted N-heteroaroylguanidin, preparation, pharmaceutical application and medicine containg same
10/30/2001US6310181 Adaptor protein FRS2 and related products and methods
10/30/2001US6310103 Administering to a mammal suffering from urinary incontinence incontinence while reducing adverse effect associted with racemic or r-enantiiomer of tolterodine, a s(-)-2-(alpha-(2-(diisopropylamino)ethyl)benzyl)-p-cresol
10/30/2001US6310079 Non-steroidal antiinflammatory agents
10/30/2001US6309856 Human MAD proteins and uses thereof
10/30/2001US6309854 Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72
10/25/2001WO2001079480A1 Albumin fusion proteins
10/25/2001WO2001079455A1 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN
10/25/2001WO2001079444A2 Albumin fusion proteins
10/25/2001WO2001079443A2 Albumin fusion proteins
10/25/2001WO2001079442A2 Albumin fusion proteins
10/25/2001WO2001079282A2 Molecules associated with human reproduction
10/25/2001WO2001079277A2 Immunogenic pili presenting foreign peptides, their production and use
10/25/2001WO2001079271A1 Albumin fusion proteins
10/25/2001WO2001079258A1 Albumin fusion proteins
10/25/2001WO2001079256A1 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them
10/25/2001WO2001079180A2 5-substituted tetralones as inhibitors of ras farnesyl transferase
10/25/2001WO2001078759A1 The use of des-aspartate-angiotensin i as an agent for the treatment and prevention of glomerulosclerosis and renal failure
10/25/2001WO2001078754A2 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
10/25/2001WO2001078713A1 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
10/25/2001WO2001078529A2 Compositions and methods for improving vascular health
10/25/2001WO2001049288A9 Novel compounds and compositions as protease inhibitors
10/25/2001WO2001027113A3 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES
10/25/2001WO2001012790A3 Isomerase proteins
10/25/2001WO2000061541A8 Pharmaceutical compounds
10/25/2001WO2000056737A9 Calanolides for inhibiting btk
10/25/2001US20010034359 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
10/25/2001US20010034340 Hormone replacement therapy
10/25/2001US20010034331 Isolated polypeptide
10/25/2001US20010034328 Treatment of male chronic pelvic pain syndrome
10/25/2001DE10019062A1 Use of known and new 2-guanidino-4-aryl-quinazoline derivatives as NHE-3 inhibitors useful for the treatment of e.g. hypertension, thrombosis, cardiac ischemia, peripheral and CNS ischemia
10/25/2001CA2747325A1 Albumin fusion proteins
10/25/2001CA2405709A1 Albumin fusion proteins
10/25/2001CA2405701A1 Albumin fusion proteins
10/25/2001CA2405696A1 5-substituted tetralones as inhibitors of ras farnesyl transferase
10/25/2001CA2405563A1 Albumin fusion proteins
10/25/2001CA2405557A1 Albumin fusion proteins
10/25/2001CA2405550A1 Albumin fusion proteins
10/25/2001CA2405525A1 Albumin fusion proteins
10/25/2001CA2405451A1 Molecules associated with human reproduction
1 ... 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 ... 562